Post-thrombotic syndrome is common after deep-vein thrombosis and can cause severe symptoms involving the limbs that impair patients’ activity and quality of life. Endovascular therapy can ...

The trial plans to enrol approximately 518 participants.

Guidelines recommend a trial of antiarrhythmic drugs before catheter ablation for persistent atrial fibrillation. Whether pulsed field ablation (PFA) may be a preferred initial treatment is ...

The adrenergic antagonist improved near vision in adults with presbyopia, with over 20 hours of improvement from a single ...

For decades, a diagnosis of metastatic pancreatic cancer has carried one of the shortest survival timelines in oncology.

Regulatory milestones include EMA approval in 2024 and FDA approval in 2025 for chronic hand eczema, addressing limitations ...

Axena Health, Inc., a women's health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced a new publication entitled ...

Alliance A222001: Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer Neoadjuvant approaches for HER2-positive breast ...

A phase II randomized study of neoadjuvant pembrolizumab (P) alone or in combination with vidutolimod (V) in high-risk resectable melanoma: ECOG-ACRIN EA6194. This is an ASCO Meeting Abstract from the ...

Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...